William R. Lenderking, PhD

Senior Research Scientist
Center for Health Outcomes Research

William Lenderking, PhD, is responsible for instrument development and validation, as well as design and management of research studies focused on patient-reported outcomes.

Also a clinical psychologist, Dr. Lenderking has 17 years’ experience in outcomes research. He began his career as a post-doc at Harvard School of Public Health with the AIDS Clinical Trials Group, held a staff position in the Psychiatry Department at Massachusetts General Hospital and later became an assistant clinical professor at Harvard Medical School.

Prior to joining UBC, he served for seven years as a Director and Team Leader with Worldwide Outcomes Research for Pfizer Inc. Prior to joining Pfizer, Dr. Lenderking was a consultant to the pharmaceutical industry with Phase V Technologies, Inc. and Abt Associates, where he worked as a psychometrician.

He has also served as Co-Editor for Quality of Life at Value in Health since 1999 and Associate Editor of Quality of Life Research from 2000 to 2003. Dr. Lenderking contributed to the Pfizer and ISOQOL responses to the FDA PRO draft guidance issued in February 2006, co-led two ISOQOL symposia on the draft guidance and a contributed workshop, and is part of the ISPOR Task Force working on a white paper describing validation issues for e-PRO technology.

Dr. Lenderking received his B.A. in Anthropology from Dartmouth College and his M.A. and PhD in Clinical Psychology from the University of Connecticut.

Close window